Altace - Newsfeeds

FDA: safety information on diabetes drug Rosiglitazone
Xagena Medical News - The Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication ( DREAM ) Study The DREAM study is a placebo-controlled, randomized, double-blind clinical trial in pre-diabetic patients designed to determine if the use of early treatment ...
Statement of Moncef Slaoui, PhD, Chairman Research & Development ...
Phramalive.com - It was designed to determine if either ramipril, a drug with well-established benefits on cardiovascular events, or Avandia(R) delayed the onset of diabetes in comparison with placebo. The trial also collected cardiovascular safety information. The ...
Statement of Moncef Slaoui, PhD, Chairman Research & Development ...
MSN MoneyCentral - It was designed to determine if either ramipril, a drug with well-established benefits on cardiovascular events, or Avandia(R) delayed the onset of diabetes in comparison with placebo. The trial also collected cardiovascular safety information ...
Heart Attack
nbc4.com - ACE inhibitors (such as ramipril, lisinopril, enalapril, or captopril) are used to prevent heart failure and lower blood pressure. SURGERY AND OTHER PROCEDURES A procedure called angioplasty may be needed to open blocked coronary arteries. This ...
Research and Markets: Analyze Dr Reddy's - the Second Largest ...
Phramalive.com - The company's current best selling product is ramipril (Altace, King Pharmaceuticals), first introduced in non-US markets in 2003. Sales of ramipril amounted to Rs 1,314.2 million in 2004, equal to 6.5% of total company revenues. In 2005, the company ...
King Pharma Rises on Analyst Praise
Forbes - He predicted a slightly lower tax rate for the company, and reduced his yearly estimates for sales of chronic pain drug Avinza and the tablet form of Altace, a blood pressure medication. Hazlett maintained a "Market Perform" rating and $20 price ...
King Fights for Its Empire
Motley Fool - With its top product Altace potentially facing generic competition by 2009, I'd expect an acquisition sooner rather than later. King's future also lies with its acquired pipeline products like the abuse-resistant pain drug, Remoxy, which it is ...
Mylan Labs in Deal to Buy German Generic Drug Unit
Stockhouse Canada - Two years ago, Mylan failed in its $4 billion bid to buy King Pharmaceuticals, based in Bristol, Tenn., which makes the heart pill Altace. Mylan specializes in copies of brand-name medicines that are difficult to make, like Johnson & Johnson's ...
King Pharmaceuticals reports 1Q earnings for 2007
TriCities.com - The company’s top three products are blood pressure medication, Altace, muscle relaxant, Skelaxin, and Thrombin-JMI, a liquid used to control bleeding during surgery. Skelaxin sales rose 14 percent to $112 million compared to $99 million during the ...
Alzheimer’s Disease - Lisinopril and Certain ACE Inhibitors Lower ...
Best Syndication - Centrally acting drugs include captropril (Capoten®), fosinopril (Monopril®), lisinopril (Prinivil® or Zestri®), perindopril (Aceon®), ramipril (Altace®) and trandolapril (Mavik®). Not all ACE inhibitors are the same. Those that do not cross ...
Some Hypertension Drugs May Help Reduce Dementia Risk
Science Daily - Centrally acting drugs include captropril (Capoten®), fosinopril (Monopril®), lisinopril (Prinivil® or Zestri®), perindopril (Aceon®), ramipril (Altace®) and trandolapril (Mavik®). The study found a link between taking centrally active ACE ...
Some hypertension drugs may help reduce dementia risk
EurekAlert - Centrally acting drugs include captropril (Capoten®), fosinopril (Monopril®), lisinopril (Prinivil® or Zestri®), perindopril (Aceon®), ramipril (Altace®) and trandolapril (Mavik®). The study found a link between taking centrally active ACE ...
Centrally Active ACE Inhibitors Linked to Lower Rates of Mental ...
Medscape News - Centrally active ACEIs, such as captropril ( Capoten ), fosinopril ( Monopril ), lisinopril ( Prinivil or Zestril ), perindopril ( Aceon ), ramipril ( Altace ), and trandolapril ( Mavik ), cross the blood-brain barrier. Previous animal studies suggest that ...
Heart Attack
Click10.com - ACE inhibitors (such as ramipril, lisinopril, enalapril, or captopril) are used to prevent heart failure and lower blood pressure. SURGERY AND OTHER PROCEDURES A procedure called angioplasty may be needed to open blocked coronary arteries. This ...
Heart Attack
Click2Houston.com - ACE inhibitors (such as ramipril, lisinopril, enalapril, or captopril) are used to prevent heart failure and lower blood pressure. SURGERY AND OTHER PROCEDURES A procedure called angioplasty may be needed to open blocked coronary arteries. This ...
Tekturna First New Type of High Blood Pressure Medicine
eMaxHealth.com - A second study presented at the meeting compared Tekturna (150 mg or 300 mg alone or 300 mg in combination with HCTZ) to ramipril (5 mg or 10 mg alone or 10 mg in combination with HCTZ), another high blood pressure medicine in a class known as ...
Take Action to Reduce Heart Disease and Stroke
14 WFIE - This study, which used the ACE inhibitor ramipril, showed that people with diabetes over the age of 55 could reduce their risk for heart attack, stroke and death by adding an ACE inhibitor to their treatment plan. In fact, the American Diabetes ...
Even 'high normal' glucose levels may increase the risk of ...
innovations report - To examine the relationship between blood glucose levels and congestive heart failure, Held and colleagues performed an interim analysis on the blinded data from the ONgoing Telmisartan Alone and in combination with the Ramipril Global Endpoint Trial ...
Zacks Bull and Bear of the Day Highlights: 51job, Hewitt Associates ...
MSN MoneyCentral - Key products like Altace and Skelaxin are likely to face generic competition within the next 1-3 years. Pride International's PDE fourth quarter results came in modestly lower that expected, reflecting higher costs from the Brazilian joint ...
King Pharmaceuticals CEO says 2006 'a good year'
TriCities.com - The company’s top three drugs are blood pressure medication Altace, muscle relaxant Skelaxin, and Thrombin-JMI, a liquid used to control bleeding during surgery. For 2006, Altace sales rose to $653 million, compared to $554 million in 2005. "We’ve ...
Looking for a District of Columbia Altace attorney? Get in touch with one of our District of Columbia Altace attorneys now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.


Pages:   1   2   3   4   5   6   ...   Next

Need An Altace Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Looking for a District of Columbia Altace attorney? Get in touch with one of our District of Columbia Altace attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Altace Case - Submit Your Information Below

Do you need legal assistance with your Altace case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Altace Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.